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ABSTRACT
Steroid receptors were classically described for
regulating transcription by binding to target gene
promoters. However, genome-wide studies reveal
that steroid receptors-binding sites are mainly
located at intragenic regions. To determine the
role of these sites, we examined the effect of pro-
gestins on the transcription of the bcl-x gene, where
only intragenic progesterone receptor-binding sites
(PRbs) were identified. We found that in response to
hormone treatment, the PR is recruited to these
sites along with two histone acetyltransferases
CREB-binding protein (CBP) and GCN5, leading
to an increase in histone H3 and H4 acetylation
and to the binding of the SWI/SNF complex.
Concomitant, a more relaxed chromatin was
detected along bcl-x gene mainly in the regions sur-
rounding the intragenic PRbs. PR also mediated the
recruitment of the positive elongation factor pTEFb,
favoring RNA polymerase II (Pol II) elongation
activity. Together these events promoted the re-dis-
tribution of the active Pol II toward the 30-end of the
gene and a decrease in the ratio between proximal
and distal transcription. These results suggest a
novel mechanism by which PR regulates gene ex-
pression by facilitating the proper passage of the
polymerase along hormone-dependent genes.
INTRODUCTION
The regulation of speciﬁc patterns of gene expression is the
main way by which cells respond to physiological and
environmental signals. The ﬁrst step in gene expression
regulation is the control of the RNA polymerase II (Pol
II)-dependent transcriptional response, which presents dif-
ferent points of exquisite control. In fact, most eukaryotic
genomes are organized into a chromatin structure that
generates high DNA package. This complex template
acts as a barrier for Pol II transcription that provides
several points for ﬁne-tune regulation. The basic unit of
chromatin is the nucleosome, composed of 147 bp of
DNA wrapped in 1.67 left-handed superhelical turns
around a histone octamer consisting of two copies each
of the core histones H2A, H2B, H3 and H4 (1). Thus, the
regulation of gene expression implies mechanisms that
allow transcription factors (TFs) to gain access to chro-
matin packaged DNA (2). After DNA binding, activated
TFs favor the recruitment of chromatin-modifying
complexes that can either modify histone residues or use
the energy of adenosine triphosphate (ATP) hydrolysis to
alter the interaction between histones and DNA (3,4).
Particularly, nuclear receptors (NRs) belong to a large
and evolutionarily conserved superfamily of ligand-de-
pendent TFs, which mediate the physiological effects of
thyroid, retinoid and steroid hormones and play key roles
in a wide variety of physiological and pathological
processes (5,6). The classical mechanisms of NRs-depend-
ent gene expression induction explains that after hormone
interaction, the NR–ligand complex binds to speciﬁc
*To whom correspondence should be addressed. Tel: +54 11 4576 3300; Fax: +54 11 4576 3342; Email: apecci@qb.fcen.uba.ar
Correspondence may also be addressed to Guillermo P. Vicent. Tel: +34 93 316 0115; Fax: +34 93 316 0099; Email: guillermo.vicent@crg.es.
The authors wish it to be known that, in their opinion, the ﬁrst two authors should be regarded as joint First Authors.
6072–6086 Nucleic Acids Research, 2013, Vol. 41, No. 12 Published online 2 May 2013
doi:10.1093/nar/gkt327
 The Author(s) 2013. Published by Oxford University Press.
This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/
by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial
re-use, please contact journals.permissions@oup.com
hormone response elements (HREs) located in the
promoter/enhancer region of target genes. On binding to
DNA, NR–ligand complexes favor the formation of the
pre-initiation complex (PIC) and transcription initiation
(7) by provoking the recruitment of NRs co-activators
as the histone acetyltransferases (HATs): CREB-binding
protein (CBP), p300, SRC1/2/3 and the P300/CBP-
associated factor (PCAF), among others (8). HAT
enzymes reduce the net positive charge of the basic
histones by acetylating speciﬁc histone residues and also
create a dynamic platform for the recruitment of some
ATP/dependent remodelers, as SWI/SNF and hNURF
(9–11). Together, these remodelers open the chromatin
structure by displacing or sliding the histone H2A/H2B
dimers or the whole nucleosomes, exposing regulating
sequences.
Genome-wide localization studies, performed with dif-
ferent NRs, have allowed the identiﬁcation of cis-regula-
tory sites in previously unexplored regions of the genome,
i.e far upstream sequences and 30-end of target genes but
surprisingly, mainly at intragenic regions (12–15). The role
of these NRs-binding sites is still unknown and opens new
questions regarding the way they operate and their func-
tional relevance. In this sense, a new mechanism of action
for NRs was recently proposed by Kininis et al. They
found that after estradiol treatment, the estrogen receptor
(ER) binds to target gene promoters and regulates the
transition from initiation to elongation (16,17). This
effect involves the ER-dependent recruitment of the
positive elongation factor P-TEFb (conformed by
multiple cyclin T subunits and the kinase Cdk9) to the
promoter regions (18) and the consecuent displacement
of negative elongation factors, leading to the transition
of the paused Pol II to a productive elongation phase
(16,19). The androgen receptor (AR) was also described
as a putative regulator of transcription elongation by
interacting with TFIIH and pTEFb at the promoter
region of the prostate-speciﬁc antigen gene, enhancing
transcription efﬁciency of its distal region on androgen
induction (20). In this sense, both studies (16,20)
contributed in understanding the mechanism of action of
NRs by focusing on the regulation of transcription initi-
ation and the transition to productive elongation.
However, the role of steroid receptors (SRs) on the elong-
ation process has not been fully addressed. In fact, these
intragenic distal binding sites (15,21,22) would correspond
to the largest part of the hormone-dependent gene regula-
tory network. Suggestively, different HATs and ATP-de-
pendent chromatin remodelers associated to SRs effects
on promoter regions have also been found regulating
acetylation, eviction and methylation of nucleosomes in
transcribed coding regions (23). Moreover, the modula-
tion of intragenic chromatin conformation was associated
with changes in Pol II elongation efﬁciency independently
of transcription initiation regulation (20,24–26).
All together, these ﬁndings suggest that SRs may favor
not only PIC formation and transcription initiation, as
classically shown, and the transition from initiation to
elongation step but also the Pol II elongation process
itself by locally recruiting chromatin modiﬁers and elong-
ation factors to speciﬁc intragenic sequences.
To evaluate this hypothesis, we analyzed progestin-de-
pendent expression induction of the endogenous bcl-x
gene in the human breast cancer cell line T47D. Bcl-x is
an apoptosis regulator that codes for two different alter-
native splicing isoforms: Bcl-xL, which prevents apop-
tosis, and Bcl-xS, which induces cell death. The genomic
structure of the human bcl-x gene contains three distinct
promoters and only two coding exons separated each
other by a long intron of 55 kb. This gene has been
found to play a critical role in cell survival during tumor
progression and chemotherapeutic resistance in mammary
gland (27–29). In particular, bcl-x is induced by progestins
in T47D (30) whose mechanism is still unknown.
In the present report, we discovered several intragenic
progesterone receptor-binding sites (PRbs) in the bcl-x
gene, which mediate hormone-dependent transcriptional
induction in breast cancer cells. After hormone addition,
the activated PR triggers the recruitment of three classes
of co-activators to these intragenic binding sites: (i) the
HATs -CBP and GCN5-, (ii) the ATP-dependent chroma-
tin remodeler SWI/SNF and (ii) the P-TEFb elongation
complex. This effect correlates with an increase in histone
acetylation levels, a partial depletion in nucleosome occu-
pancy, a re-distribution of the elongating Pol II torward
the 30-end of the gene, a decrease in the ratio between
proximal and distal transcription and a change in the
relative abundance between both alternative spliced bcl-x
isoforms, favoring the accumulation of bcl-xL. In turn, we
have found that the distribution of PRbs along the bcl-x
gene would allow the loading of chromatin remodeling
complexes, as well as elongation factors, both shown as
key elements during gene induction by progestins. All
together, these results suggest a novel mechanism, comple-
mentary to the classical model of NRs-dependent gene
expression regulation, where PR would regulate the tran-
scription levels of target genes by modulating the elong-
ation process through intragenic binding sites.
MATERIALS AND METHODS
Plasmid constructions
The constructs p2.2hbcl-x-LUC; p3.5hbcl-x-LUC;
p42hbcl-x-LUC and p58hbcl-x-LUC (expressing luciferase
reporter gene under the control of SV40 minimal
promoter plus hbcl-x fragment+2.2,+3.5,+42 and+58,
respectively) were generated by subcloning the corres-
ponding inserts into pGL3 reporter vector (Promega)
into SacI/XhoI restriction sites.
Cell culture and transient transfection assays
T47D breast cancer cells were routinely grown in Roswell
Park Memorial Institute medium (RPMI) 1640 medium
supplemented with 10% Fetal Bovine Serum (FBS),
2mM L-glutamine, 100U/ml of penicillin and 100 mg/ml
of streptomycin. For the experiments, cells were plated in
RPMI medium without phenol red supplemented with
10% dextran-coated charcoal-treated FBS (DCC/FBS),
and 48 h later medium was replaced by fresh medium
without serum. After 24 h in serum-free conditions, cells
were incubated with R5020 (10 nM) for different times at
Nucleic Acids Research, 2013, Vol. 41, No. 12 6073
37C. For transient transfections, 4 105 T47D cells were
co-transfected with 2 mg of each hbcl-x-LUC constructs
and 2 mg of pCMV-LacZ using Lipofectamine 2000
(Invitrogen). After transfection, the cells were treated
with R5020 for 36 h and then harvested in lysis buffer.
Luciferase activity was measured with the Promega
luciferase kit according to the manufacturer protocol
and b-galactosidase as described before (31).
Chromatin immunoprecipitation assays
Chromatin immunoprecipitation (ChIP) assays were
performed as previously described (32) using anti-PR
(sc-7208), anti-CBP (sc-369), anti-GCN5 (sc-20698), anti-
CDK9 (sc-484) and anti-total Pol II Clone 8WG16 (sc-
899X), from Santa Cruz Biotechology. Anti-H2A and
anti-H4 were supplied by Dr Stefan Dimitrov, Grenoble,
France. Anti-H3 (ab1791), anti-H3K9ac (ab4441) and
anti-H3K14ac (ab46984) from Abcam. Anti-H4K8ac
(07-328), anti-H4K12ac (07-595), anti-H4panac (06-598)
and anti-H3K18ac (07-354) from Upstate-Millipore.
Anti-BAF57 (A300-810A) from Bethyl, and IgG (kch-
504-250) from Diagenode, which was used as a negative
control. An anti-total Pol II Clone 8WG16 (Covance) was
used for Pol II ChIPs in 5,6-dichlorobenzimidazone-1-b-
D-ribofuranoside (DRB)-treated assays. Speciﬁc ChIPs
against Pol II-Ser2P were done as described previously
(33) by using the speciﬁc antibody anti-Pol II-Ser2P
Clone H5 (Covance-MMS-129R). Quantiﬁcation of
chromatin immunoprecipitation was performed by
real-time polymerase chain reaction (PCR) using Roche
Lightcycler (Roche) or DNA Engine OpticonTM
System cycler (MJ Research). The fold enrichment of
target sequence in the immunoprecipitated (IP)
compared with input (Ref) fractions was calculated
using the comparative Ct (the number of cycles required
to reach a threshold concentration) method with the
equation 2Ct(IP)–Ct(Ref). Each of these values were corrected
by the human b-globin gene and referred as relative abun-
dance over time zero. Primers sequences are available on
request.
RNA interference experiments
siRNA GCN5 (sc-37946) and siRNA CBP (sc-29244)
from Santa Cruz Biotechnology were transfected into
the T47D cells using Lipofectamine 2000 (Invitrogen).
After 48 h, the medium was replaced by fresh medium
without serum. After one day in serum-free conditions,
cells were incubated with R5020 (10 nM) or vehicle
(ethanol) for different times at 37C. The downregulation
of CBP and GCN5 expression was determined by western
blotting.
RNA extraction and reverse transcriptase–PCR
Total RNA was prepared and cDNA generated as previ-
ously described (34). Quantiﬁcation of gene products was
performed by real-time PCR. Each value calculated using
the standard curve method was corrected by the human
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
and expressed as relative RNA abundance over time
zero. Primer sequences are available on request.
Coimmunoprecipitation assays
Cells were lysed in IP buffer (50mM Tris–HCl, pH 7.4,
130mM NaCl, 1mM ethylenediaminetetraacetic acid,
1mM ethylene glycol tetraacetic acid (EGTA), 5mM
MgCl, 1% Triton X-100 and 0.2mg/ml of bovine serum
albumin and protease inhibitors) and sonicated three
times for 10 s at 20% output with a Branson 450
Soniﬁer. Cell extracts (1mg protein) were incubated with
protein A/G agarose beads (Oncogene) previously coupled
with 3 mg of the corresponding antibodies or an unspeciﬁc
control antibody. The immunoprecipitated proteins were
eluted by boiling in sodium dodecyl sulfate—sample
buffer. Inputs and IPs were analyzed by western blot
using PR, CBP, GCN5 and CDK9 antibodies and the
anti-cyclinT1 antibody (sc-8127X), from Santa Cruz
Biotechology.
DNaseI hypersensitive assays
DNaseI hypersensitivesites (DHS) were identiﬁed as pre-
viously described (35). Digested DNA was used for deep
sequencing using the Solexa Genome Analyzer.
Pol II elongation rate evaluation
T47D cells were treated with 100 mMDRB (Sigma) for 3 h.
Then, cells were washed twice with phosphate-buffered
saline, incubated in fresh medium in the presense of
R5020 or vehicle for different times and total RNA was
purifyed using the RNeasy kit (Qiagen). Reverse tran-
scriptase (RT)–qPCR were performed as previously
described with speciﬁc primers for proximal and distal
regions of the bcl-x pre-mRNAs. Primer sequences are
available on request.
Statistical analysis
Results were expressed as means±standard error.
Statistical analyses were performed with STATISTICA
6.0 (StatSoft, Inc.) and consisted of one- or two-way
ANOVA followed by Tukey’s multiple comparisons
tests. Differences were regarded as signiﬁcant at
P< 0.05. Before statistical analysis, data were tested for
normality and homoscedasticity using Lilliefors and
Bartlett’s tests, respectively. In some cases, log-trans-
formed or root square-transformed data were used. In
all cases, bars with different superscript letters are signiﬁ-
cantly different from each other.
RESULTS
Characterization of intragenic PR-binding sites on
bcl-x gene
Genome-wide distribution of PRbs detected by ChIP-seq
performed in human T47D cells treated during 60min
with the synthetic progestin R5020 (108M) showed that
31% of PRbs are located in introns and 4% in exons,
whereas the rest does not overlap with protein coding
regions (22). One example of intragenic PRbs is found in
the bcl-x gene (bcl2l1), one of the genes induced by pro-
gestins in T47D cells (36). To conﬁrm that bcl-x is a direct
target of progestins, we determined bcl-x mRNA levels on
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hormone addition in the presence or absence of RNA and
protein synthesis inhibitors. Although induction of bcl-x
transcripts was blocked in the presence of the transcrip-
tion inhibitor a-amanitin (a-Am), cycloheximide
(Cyclohex) did not inﬂuence bcl-x induction (Figure 1A),
demonstrating that it is not dependent on protein synthe-
sis. In agreement with a direct effect of progestins on bcl-x
expression, we found four clusters of intragenic PRbs
located at: +2.2, +3.5, +42 and+58kb as counted from
the more active bcl-x promoter (P1A) (Figure 1B). The
ﬁrst three sites are placed in the long intronic region,
whereas the +58 kb site localizes at the end of the last
exon. To validate the recruitment of PR to the bcl-x
intragenic sites, we perfomed ChIP–qPCR experiments
in T47D cells treated or not treated with R5020 for
60min, focusing on the intragenic PR-binding sites but
also on the promoters and enhancer regions located up
to 3.5 kb upstream the transcriptional start site (TSS)
(Figure 1B and C). We found that PR is recruited to the
+2.2, +3.5, +42 and+58 sites, and that recruitment was
higher close to the 30-end of the gene. No recruitment of
PR was observed either in the promoter regions (P1A, AB,
P1B or P2) or in the enhancer region (R1–R5). ChIP-seq
results have also shown no PR recruitment up to 10 kb
upstream of the bcl-x promoter (22). Interestingly, a
fraction of the PR recruited to bcl-x was phosphoryled
at Ser-294, suggesting that it was activated on hormone
addition (Supplementary Figure S1A) (34).
To explore the kinetics of recruitment, we perfomed
ChIP–qPCR experiments at different times after
hormone addition. Initially, at 1 and 5min, PR was re-
cruited similarly to all sites, but after 30min, a different
Figure 1. Progestin-dependent bcl-x expression. (A) T47D cells were treated or not treated with R5020 for 6 h in the presence or absence of
a-amanitin or cycloheximide, and total RNA was prepared. cDNA was generated and used as template for real-time PCR with bcl-x-speciﬁc
primers. The values were normalized with gapdh expression. The histograms show the mean±standard deviation (SD) of three experiments per-
formed in triplicate. Different superscript letters are signiﬁcantly different from each other (P 0.05). (B) Scheme of the human bcl-x gene structure:
R1–R5 sites indicate TSS upstream regions; P1A, P1B or P2 indicate promoter regions and +2.2, 3.4, +42 and +58 indicate PRbs.
Immunoprecipitation with normal rabbit IgG (IgG) was used as control. (C) Recruitment of PR to the TSS upstream regions, promoter regions
and PRbs. T47D cells were treated with R5020 for 60min and subjected to ChIP assays with a-PR. The histograms show the mean±SD of three
experiments performed in triplicate. Different superscript letters are signiﬁcantly different from each other (P 0.05). (D) T47D cells were transiently
transfected with luciferase reporter constructs containing the sequence encompassing the different PRbs. After transfection, the cells were treated with
R5020 for 36 h, and luciferase activity was measured. The values represent the mean and standard deviation from three experiments performed in
duplicate. Different superscript letters are signiﬁcantly different from each other (P 0.05).
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pattern of binding was detected, with more PR recruited
to the sites closer to the 30-end of the gene (Supplementary
Figure S1B). Thus, on progestin stimulation, activated PR
is rapidly recruited to intragenic PRbs, but it remains
bound to each of them for different times.
To assess the capacity to mediate hormone responsive-
ness of the intragenic PRbs, DNA fragments encompass-
ing each of the PRbs at +2.2, +3.5, +42 and +58 were
subcloned into luciferase reporter vector and transfected
into T47D cells, which were then treated or not treated
with R5020. Our results showed that the four intragenic
elements signiﬁcantly responded to the hormone induc-
tion, indicating that they contain sequences responsible
for the hormone-dependent bcl-x expression behaving as
bona ﬁde HREs (Figure 1D).
Histone acetyltransferases CBP and GCN5 are needed for
bcl-x induction and are recruited to its intragentic PRbs
via association with PR
Acetylation of histones is often associated to gene
activaton, and many NR co-activators exhibit HAT
activities as, for example, CBP and GCN5 (8). Thus, we
transfected T47D cells with speciﬁc siRNAs against these
two HATs and then treated them with R5020. Bcl-x ex-
pression was measured by RT–qPCR, whereas the protein
levels of CBP and GCN5 with either control or speciﬁc
siRNAs were determined by western blotting (Figure 2A).
Quantitative evaluation of CBP and GCN5 protein levels
yielded a degree of depletion of 80 and 50%, respectively;
under these conditions, hormone-dependent bcl-x induc-
tion was signiﬁcantly compromised (Figure 2A, top).
However, knockdown of PCAF, a different HAT that
has been found also associated to NRs (37,38) did not
show any effect on bcl-x expression regulation (unpub-
lished observations). Accordingly, overexpression of the
histone deacetylases HDAC1 and HDAC2 also prevented
hormone-dependent bcl-x induction (Supplementary
Figure S2). Moreover, ChIPs assays performed using
speciﬁc antibodies for CBP and GCN5 showed that both
HATs are recruited to the intragenic PRbs on 60min of
hormone treatment to an extent correlated to the previ-
ously observed binding of PR (compare Figures 1C and
2B). Together these results suggest that CBP and GCN5
histone acetylases are involved as direct mediators of the
PR-dependent bcl-x transcription regulation.
As HATs may also be recruited to the chromatin by the
elongating Pol II (39–42), we re-analyzed the recruitment
of CBP and GCN5 in T47D but not in cells pre-treated
with the elongation inhibitor DRB (43), which inhibits the
activity of the kinase subunit CDK9 of the P-TEFb
complex (44). Bcl-x induction after R5020 addition was
blocked by DRB in a dose-dependent manner
(Supplementary Figure S3). Thus, we performed ChIP
assays to analyze the recruitment of PR, CBP and
GCN5 in cells pretreated with 50 mM of DRB for 1 h
and then incubated with R5020 in the presence of the in-
hibitor. Recruitment of PR, CBP and GCN5 to the
intragenic PRbs was not affected by the presence of
DRB (Figure 2C), suggesting that recruitment of PR
and the two HATs is independent of RNA Pol II
elongation. Moreover, co-IP experiments performed with
protein extracts from T47D cells treated or not treated
with R5020, showed that both HATs interact with PR,
and that the association is hormone dependent for CBP
but not for GCN5 (Figure 2D). Thus, likely the HATs are
recruited to the intragenics PRbs of bcl-x via an inter-
action with PR.
Changes in chromatin accessibility in the distal intragenic
PRbs
Several studies have shown that nucleosomes constitute a
strong barrier for elongating polymerases. Therefore, we
next wondered whether changes in the chromatin structure
could be involved on PR-dependent regulation of bcl-x
expression. To assess this question, we performed
ChIP experiments using speciﬁc antibodies recognizing
histones H2A, H3 and H4. Our results show a signiﬁcant
decrease (between 20 and 40%) on histone H2A, H3 and
H4 content after hormone addition, at the intragenic sites:
+3.5,+42 and+58 (Figure 3A). The degree of histones H3
and H4 removal from the intragenic PRbs was similar to
the displacement of H2A/H2B dimers (Figure 3A,
compare left with middle and right), suggesting that
whole nucleosomes loose interaction with DNA rather
than just the dimers of H2A–H2B. The presence of
DRB did not block histone displacement, indicating that
this process seems to be PR dependent rather than a con-
sequence of histone eviction associated to the elongating
activity of the Pol II (Figure 3B). Analysis of histone levels
along the bcl-x gene before and after hormone addition
showed that hormone-dependent chromatin remodeling
was enriched in the PRbs surrounding regions
(Figure 3C), suggesting that the strong binding of
activated PR triggers these changes in nucleosome occu-
pancy. In this sense, histone displacement was not
observed at the promoter P1A (Figure 3A and C).
Moreover, the analysis of read proﬁles obtained
from ChIP-seq of H4 showed that histone displacement
is most clearly seen toward the 30-end of the gene
(Figure 3D) correlating with the enhanced binding of the
receptor, as well as GCN5 and CBP recruitment
(Figures 1C and 2B).
Next, we investigated whether recruitment of CBP and
GCN5 to the intragenic PRbs correlates with changes in
histone acetylation. We performed ChIP assays using
speciﬁc antibodies against either pan-acetylated H4 or in-
dividual acetylated lysines: K8 and K12 of H4 and K18,
K14 and K9 of H3. The results were normalized to the
levels of histones H3 and H4 in each case (Figure 3E) and
show that after hormone induction, the acetylation of
histones H3 and H4 is increased between 1.5- and 2.7-
fold at the +3.5, +42 and+58 intragenic PRbs, whereas
only a moderate increase is observed at the promoter
region P1A (Figure 3E). Both CBP and GCN5 participate
in the acetylation at intragenic PRbs, as we observed
increased levels of H3K9ac and H4K8ac that are exclu-
sively placed by GCN5 and CBP, respectively (Figure 3E).
Moreover, we detected a moderate increase in H3K14ac
that could be catalyzed by another HAT (9). We also
observed increased levels of H4K12ac (Figure 3E), a
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modiﬁcation that it cannot be produced by neither by
GCN5 nor CBP (45), indicating that other HATs, as
hKAT1/(HAT1), hKAT5/(TIP60) or hKAT7/HBO1/
MYST2 could also be involved in the histone acetylation
process occurring in the bcl-x intragenic PRbs.
Furthermore, according to ChIP assays performed
against H3K14ac, H4panac and H4K8ac analyzed along
bcl-x, histone acetylation also seems to be mainly
increased at the 30-region of the gene (Figure 3F).
As shown previously, some chromatin remodelers, such
as SWI/SNF (BAF and P/BAF complexes) and NURF,
contain subunits that recognized speciﬁc histone acetyl-
ation marks and, therefore, cooperate in their binding to
target chromatin (9,46). ChIP experiments showed a sig-
niﬁcant hormone-dependent recruitment of BAF57, a
subunit of the BAF complex to the +3.5, +42 and +58
PRbs, to a level correlated to the extent of PR and HAT
recruitment (Figure 3G).
As the recruitment of the SWI/SNF chromatin remodel-
ing enzymes is one of the mechanisms likely to disrupt chro-
matin at many DHS (47–49), we next asked whether speciﬁc
binding of PR along with chromatin remodelers to the
intragenic PRbs changes the DHS pattern after hormone
induction. In this sense, we searched for DHS at the bcl-x
gene by analyzing a DNase I hypersensitive sites sequencing
(DNase I-seq) assay performed in T47D cells treated or not
treated for 60min with R5020 (22). Results showed an
increase in DHS at the intragenic PRbs at +42 and +58
on hormone addition (Figure 4, top and bottom). The
regions over the intragenic PRbs at +2.5 and +3.5 were
hypersensitive to DNase I before hormone treatment and
became less sensitive to nucleases in the presence of R5020
(Figure 4). Thus, the promoter distal PRbs of bcl-x showed a
clear chromatin remodeling after hormone treatment in cor-
relation with their higher binding of PR, HATs and BAF.
This different behavior of PRbs located closer to the 30 of the
gene compared with those sited more proximal to promoter
regions together with the nucleosomes displacement detected
earlier in the text suggests that the more accessible chromatin
conformation induced by PR at these sites would favor the
passage of the elongating RNA Pol II along bcl-x, mainly at
the 30-end region.
To test this hypothesis, we then directly monitored the
hormone-dependent Pol II distribution along bcl-x gene.
Analysis of the read proﬁle obtained from a ChIP-seq
showed that the Pol II is stalled in the 50-end of the gene
before hormone addition (Figure 5A, top). Hormone in-
duction promoted accumulation of Pol II toward the
Figure 2. Role of CBP and GCN5 on progestin-dependent bcl-x induction. (A) T47D cells treated or not treated with R5020 were transfected with
control, CBP or GCN5 siRNAs, then total RNA and proteins were extracted. The relative levels of bcl-x expression were determined by RT–PCR
and normalized to gapdh expression. The degree of depletion of CBP and GCN5 was monitored by western blot using speciﬁc antibodies. For each
condition, b-tubulin was used as loading control. The histograms show the mean±SD of three experiments performed in duplicate. The different
superscript letters are signiﬁcantly different from each other (P 0.05). (B) T47D cells were treated with R5020 for 60min and subjected to ChIP
assays with a-CBP- and a-GCN5-speciﬁc antibodies. Recruitment of CBP (left) and GCN5 (right) to PRbs, promoter regions and TSS upstream
regions of the bcl-x gene is shown. Immunoprecipitation with normal rabbit IgG (IgG) was used as control. The graphics show the mean±SD of
three experiments performed in duplicate. The different superscript letters are signiﬁcantly different from each other (P 0.05). (C) Effect of
transcription elongation on PR (left), CBP (middle) and GCN5 (right) recruitment to the +3.5, +42 and +58 PRbs. T47D cells pre-incubated
with 50 mM DRB were treated with R5020 for 60min and subjected to ChIP assays with a-PR, a-CBP and a-GCN5 antibodies. Immunoprecipitation
with normal rabbit IgG (IgG) was used as control. The graphics show the mean±SD of three experiments performed in duplicate. The different
superscript letters are signiﬁcantly different from each other (P 0.05). (D) T47D cells treated or not treated with R5020 for 1 h were lysed and
immunoprecipitated with a-CBP- and a-GCN5-speciﬁc antibodies or with normal rabbit IgG (IgG). The immunoprecipitates were analyzed by
western blotting with a-PR, a-CBP and a-GCN5 as indicated.
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30-end of the gene [(22) and Figure 5A, top]. Box plots
representing the density of Pol II at 50 (exon1) and 30
(exon2) bcl-x regions conﬁrmed the statistical signiﬁcance
of this ﬁnding (Figure 5A, bottom). Similar results were
obtained by using quantitative ChIP–qPCR. The magni-
tude of Pol II increase was 2-fold at the 30-region of the
gene (Figure 5B). As expected, the increase in Pol II levels
was abolished by the inhibitor DRB (Figure 5C), ruling
out the possibility of an internal Pol II recruitment as a
consequence of the activated PR binding to the intragenic
PRbs. Thus, the binding of the activated PR would affect
the internal Pol II distribution toward the 30-end rather
than the recruitment of new Pol II molecules to the
promoter region.
Taking into account that the phosphorylation of the
carboxy-terminal domain (CTD) of the largest Pol II
subunit in the Ser2 residues is a good marker of active
elongation, we performed ChIP experiments against the
Pol II-Ser2P to coﬁrm that hormone treatment affects
the elongating polymerase. Figure 5D shows that on pro-
gestin addition, the levels of the Pol II-Ser2P increased
toward the 30-end of the gene. Moreover, a time-course
curve of the Pol II-Ser2P at P1A and the+3.5, +42 and
+58 PRbs showed a similar proﬁle to the time course
Figure 4. Increase in DHS signal at the intragenic PRbs after hormone induction. T47D cells were treated with R5020 for 60min and subjected to
DNAse-seq analysis (35). Top and middle: the proﬁles of DHS signals obtained in the presence and in the absence of R5020, as well as the PRbs
obtained by ChIP-seq (22) in the bcl-x gene are shown. Bottom: Quantiﬁcation of the DHS reads associated with the+2.5,+3.5,+42 and+58 PRbs.
The window used in each PRbs was ±50bp.
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previously observed for the PR recruitment to these
internal PRbs (compare Figure 5E with Supplementary
Figure S1B). These results highlight the role of progestins
affecting the elongation rate.
P-TEFb is recruited to the intragenic PRbs on
hormone addition
As phosphorylation of Pol II-Ser2 is carried out by the
positive elongation factor P-TEFb, which is known to be
recruited by the SRs to target genes (16,19,20), and given
that bcl-x hormone-dependent induction is affected by the
inhibition of the P-TEFb subunit CDK9 (Supplementary
Figure S3), we then tested whether this elongation factor is
recruited to the bcl-x PRbs. We performed ChIP assays
with a speciﬁc antibody recognizing CDK9 in T47D cells
treated with R5020 for 60min. Consistently, we found
hormone-dependent recruitment of the CDK9 kinase to
the intragenic PRbs with a similar pattern to that
observed previously for PR and the two HATs
(Figure 6A). Moreover, CDK9 was recruited even when
its activity was impaired by the presence of DRB
(Figure 6B), supporting a PR-mediated recruitment.
Indeed, the P-TEFb subunits, CDK9 and cyclinT1, co-
precipitate with PR in response to the hormone in this
cell line (Figure 6C). As P-TEFb favors the elongation
process by phosphorylation of Pol II Ser2 and
by displacing negative elongation factors, intragenic
PR-mediated recruitment of this factor would favor pro-
gesterone enhancement of transcription elongation.
Involvement of intragenic PRbs on the transcription
elongation and alternative splicing of bcl-x
Changes in the Pol II rate or processivity on endogenous
genes in response to a particular stimulus is technically
difﬁcult to determine. However, there is a way to asses
Pol II processivity by evaluating with speciﬁc primers
the relative abundance of a pre-mRNAs in a proximal
versus a distal region by RT–qPCR, assuming that most
pre-mRNAs are co-transcriptional intermediates (50)
(Figure 7A). We used this approach to analyze Pol II
processivity on bcl-x in T47D cells treated with R5020
for 15, 30 and 60min (Figure 7B, left). Results show
that the proximal/distal ratio for bcl-x gene decreases
after hormone addition, indicating a hormone effect on
Figure 5. Occupancy of intragenic PRbs after hormone induction increased RNA pol II loading to the 30-end of the bcl-x gene. (A) T47D cells were
treated with R5020 for 60min and subjected to ChIP-seq analysis using a-RNA pol II antibody (22). Top: the read proﬁles obtained in the presence
and in the absence of hormone in the bcl-x gene are shown. Black triangles at the absice indicate PRbs location. Bottom: after hormone induction,
increased loading of RNA pol II polymerase is detected at the 30-end of the bcl-x gene. Quantiﬁcation of the ChIP-seq reads associated with the bcl-x
exon 1 (right) and 2 (left) in the presence and in the absence of hormone is shown. The P-value is indicated at the bottom of each box plot. (B) T47D
cells were treated with R5020 for 60min and subjected to ChIP assays with a-RNA Pol II antibody. The precipitated DNA fragments were subjected
to PCR analysis along bcl-x. The histograms show the mean±SD of three experiments. Different superscript letters are signiﬁcantly different from
each other (P 0.05). Black triangles at the absice indicates PRbs location. (C) Effect of transcription elongation on Pol II distribution at the+3.5,
+42 and+58 PRbs. T47D cells pre-incubated with 50 mM DRB were treated with R5020 for 60min and subjected to ChIP assays with a-RNA Pol II
antibody. Immunoprecipitation with normal rabbit IgG (IgG) was used as control. The graphics show the mean±SD of three experiments
performed in duplicate. The different superscript letters are signiﬁcantly different from each other (P 0.05). (D) T47D cells were treated with
R5020 for 60min and subjected to ChIP assays with a-RNA Pol II-Ser2P antibody. The precipitated DNA fragments were subjected to PCR analysis
along bcl-x. The histograms show the mean±SD of three experiments. Different superscript letters are signiﬁcantly different from each other
(P 0.05). Black triangles at the absice indicate PRbs location. (E) Time course of RNA Pol II-Ser2P recruitment: T47D cells were treated with
R5020 for 0, 5, 30 and 60min and subjected to ChIP assays using a-RNA Pol II-Ser2P PR antibody. The precipitated DNA fragments were
subjected to PCR analysis to test for the presence of sequences corresponding to P1A and the three PRbs:+3.5,+42 and+58 PRbs. The histograms
show the mean±SD of three experiments performed in duplicate. Different superscript letters are signiﬁcantly different from each other (P 0.05).
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Pol II elongation activity. The observed change in the
proximal/distal ratio was detected already after 15min
of hormone treatment and reached the maximum after
30min.
Taking into account that changes in Pol II
processivity inﬂuence RNA processing (24,25), and
that bcl-x alternative splicing is affected by changes in
Pol II elongation efﬁciency (51), we analyzed the
hormone-dependent regulation of bcl-x alternative
spliced isoforms. The results showed that both bcl-xL
and bcl-xS transcript levels signiﬁcantly increased on
R5020 addition (Figure 7B, middle); however, the
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Figure 6. The elongation complex pTEFb is recruited along with PR to the bcl-x intragenic PRbs. (A) T47D cells were treated with R5020 for 60min
and subjected to ChIP assays with a-Cdk9 antibody. The precipitated DNA fragments were subjected to PCR analysis to test for the presence of
sequences corresponding to+3.5,+42 and+58 PRbs. Immunoprecipitation with normal rabbit IgG (IgG) was used as control. The histograms show
the mean±SD of three experiments. Different superscript letters are signiﬁcantly different from each other (P 0.05). (B) T47D cells pre-incubated
with 50 mM DRB were treated with R5020 for 60min and subjected to ChIP assays with a-Cdk9 antibody. The precipitated DNA fragments were
subjected to PCR analysis to test for the presence of sequences corresponding to+3.5,+42 and+58 PRbs. Immunoprecipitation with normal rabbit
IgG (IgG) was used as control. The histograms show the mean ± SD of three experiments. Different superscript letters are signiﬁcantly different
from each other (P 0.05). (C) T47D cells treated or not treated with R5020 for 1 h were lysed and immunoprecipitated with a-PR or with normal
rabbit IgG (IgG). The immunoprecipitates were analyzed by western blotting with a-Cdk9, a-CyclinT1 and a-PR as indicated. Blots correspond to
one representative experiment (n=3).
Figure 7. PR-dependent Pol II processivity and bcl-x splicing. (A) Scheme of the human bcl-x gene structure: arrows indicate the sequences that
hibridize with the different primers used in these assays. (B) T47D cells were treated or not treated with R5020 for 15, 30 and 60min, and the
proximal/distal ratio of mRNA bcl-x gene was evaluated. The histograms show the mean±SD of three experiments performed in duplicate. The
different superscript letters are signiﬁcantly different from each other (P 0.05). (C) T47D cells were treated or not treated with R5020 for 6 h, and
total RNA was prepared. cDNA was generated and used as template for real-time PCR with bcl-xL and bcl-xS-speciﬁc primers (left). Right: the ratio
between bcl-xL and bcl-xS was calcultated. The values were normalized with gapdh expression. The histograms show the mean±SD of three
experiments performed in triplicate. Different superscript letters are signiﬁcantly different from each other (P 0.05).
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relative abundance between each other favors bcl-xL ac-
cumulation (right). These results add more evidences
supporting the hypothesis of a progestin-dependent
regulation of Pol II elongation.
A progesterone effect on Pol II elongation activity was
also observed in the endoplasmic reticulum to nucleus sig-
naling factor 1 (ern1) gene (Supplementary Figure S4D).
The ern1 gene like bcl-x contains intragenic PRbs and is
also upregulated in the presence of hormone
(Supplementary Figure S4A). On the other hand, other
induced hormone-dependent genes, such as transforming
growth factor a (tgf) (Supplementary Figure S4B) and
the insulin-like growth factor 1 receptor (igf1r)
(Supplementary Figure S4C), show a proximal/distal
pre-mRNA ratio that either does not change or even in-
creases after hormone, respectively (Supplementary Figure
S4E and F, respectively).
The recent progress in DNA sequencing technology
allowed us to increase the coverage 10-fold and to
identify 28.474 intragenic PRbs on 60min of hormone
treatment (P< 105). Combining the results of the ChIP-
seq of PR with the gene expression data obtained by
RNA-seq, we found that the internal PRbs are signiﬁ-
cantly enriched in upregulated genes compared with
genes that do not respond to hormone (3.2 versus 1
PRbs/gene, respectively) (Supplementary Table S1).
Interestingly, intragenic PRbs also showed a preference
for downregulated genes with 2 PRbs/gene. Thus, we
conclude that internal PRbs are accumulated in
hormone-regulated genes, suggesting a more general
mechanism than originally expected.
DISCUSSION
The study of how NRs control transcription has been
largely focused on the regulation of PIC formation and
transcription initiation. However, the putative role of NRs
on the regulation of subsequent transcriptional steps has
recently been enabled by using new generation sequencing
techniques (16). Particularly, ChIP-seq analysis showed
that NRs bind to sites located outside and sometimes at
great distances of promoters, mainly at intragenic regions
(14,16,52). However, the functional relevance and the
mechanism of action of these internal NRbs have not
been conclusively clariﬁed.
Induction of bcl-x transcription correlates with the binding
of PR to intragenic sites and the recruitment of active
CBP and GCN5
The classical model of SRs-mediated gene activation
proposes that Pol II recruitment and PIC formation to
SRs target promoters is favored by an open chromatin
structure, as demonstrated by high sensitivity to DNase
cleavage observed on hormone treatment (53,54). It is
assumed that this localized relaxed chromatin conform-
ation is generated by SR-mediated recruitment of chroma-
tin-modifying complexes that are common SR-co-factors
during gene activation or induction (8,55–58).
In this work, we found that progestin-dependent bcl-x
transcriptional induction in the breast cancer cell line
T47D is controlled by binding of PR to several intragenic
binding sites instead of the classicaly described promoter
PRbs. In response to hormone treatment, the activated PR
recruits CBP and GCN5 HATs to these sites, as was
already demostrated at target promoters. Interestingly,
the recruitment of these CBP and GCN5 is independent
of transcription elongation, as it cannot be inhibited by
DRB. CBP and GCN5 binding was acompanied by a local
increase in histones H3 and H4 acetylation and was neces-
sary for the hormone induction of bcl-x, as interfering
either CBP or GCN5 expression precluded activation of
the gene. These results, together with the co-immunopre-
cipitation of PR with both CBP and GCN5, support the
hypothesis of a PR-dependent recruitment of chromatin
modiﬁers to these intragenic regions. In fact, simultan-
eously with the recruitment of these HATs, accumulation
of the ATP-dependent chromatin remodeler SWI/SNF
and reduction in nuclesome occupancy in the bcl-x
intragenic PRbs were observed, suggesting a change in
the chromatin structure toward a more open state.
Histone displacement was not exclusively restricted to
the internal PRbs but also to surrounding regions. This
effect correlates with the presence of other PRbs with
lower levels of PR recruited than those observed at+2.5,
+3.5, +42 and +58 described here (22). These weaker
PRbs are mainly localized in the 30-region of bcl-x
intron and may contribute to the PR-dependent effect
on Pol II elongation mainly at this region of the gene.
PR-dependent remodeling of chromatin organization
was previously demonstrated at promoter regions as a
complex and necessary prerequisite for hormonal induc-
tion in a diversity of biological models (59–62). For
example, two consecutive cycles of chromatin remodeling
involving activated protein kinases, HATs and ATP-
dependent chromatin modiﬁers have been described on
hormonal induction of the mouse mammary tumor virus
(MMTV) promoter (63).
Supporting our observations, local recruitment of chro-
matin remodelers and a decrease in histone density were
found at four AR intronic sites located 90 kb down-
stream from the TSS of the fkbp51 locus in VCaP and
LNCaP prostate cancer cells, in response to the comercial
androgen R1881 (64). Thus, SRs-associated histone
acetylation and chromatin remodeling do not seem to
occur only at promoter regions but also at distal down-
stream enhancers.
It has also been described that the glucocorticoid
receptor exerts long-range regulation of fkbp51 transcrip-
tion through distal sites located 100 kb from the TSS of
the gene (65). Distal SRbs would facilitate the formation
of transcriptional chromatin loops in certain genes,
favoring the occurrence of protein–protein interactions
among TFs bound to widely separated regulatory
elements. The concept that the pre-assembled higher-
order structures of chromatin can create boundaries for
long-range interactions was also reported by Cullen et al.
(66), who described the juxtaposition of distal ER-binding
sites and proximal promoter regions of the prolactin gene
in response to estrogens. Although we cannot discard the
PR-dependent formation of chromatin loops in the bcl-x
locus and their role on Pol II activity, ChIPs-seq assays
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did not reveal PR or Pol II enrichment around the
promoter and 50-end regions of the gene, both events
expected if a promoter loop is formed. Furthermore, the
observed Pol II accumulation toward the 30-end of the
gene in response to hormone treatment suggests a local
effect of PR rather than a promoter-directed regulation.
Recent genome-wide studies have shown that nucleo-
somes downstream of paused polymerases act as
physical barriers to polymerase elongation. Therefore,
we propose that this local chromatin relaxation triggered
by the activated PR bound to the intragenic PRbs would
be involved in controling Pol II elongation along bcl-x
gene.
Chromatin remodeling complexes and P-TEFb recruited
to intragenic sites could facilitate transcription elongation
A connection between histone acetylation and transcrip-
tion elongation was also suggested by the observation that
acetylated histones regulate the recruitment of the positive
elongator factor P-TEFb (67,68). Binding of P-TEFb
would not only induce Pol II activation through the
CDK9-dependent speciﬁc phosphorylation of the CTD
but also counteract negatively acting elongation factors
that keep the Pol II stalled near promoters (69–71).
As far as the SR mechanism of action is concerned, the
regulation of pre-loaded Pol II activity has been described
as the predominant genomic outcome of ER (16). In the
absence of estrogens, a large number of ER target pro-
moters are Pol II pre-loaded with minimal occupancy over
the coding body, a phenomenon referred as pausing or
promoter proximal enrichment of Pol II (PPEP). On
hormone addition, ER binding to those promoters
triggers the recruitment of P-TEFb favoring Pol II
dispausing toward productive elongation (15). Even
more, in a recent work, it was demonstrated that recruit-
ment of the ER/P-TEFb complex to a well-know tran-
scriptional pausing site located at 1.7 kb downstream
of the TSS of c-myb gene (72) enables Pol II to resume
transcriptional elongation (17). These results reinforce the
idea that control of elongation in addition to transcription
initiation are relevant mechanisms by which SRs control
gene expression. In this sense, we propose that PR-de-
pendent recruitment of P-TEFb to the intragenic bcl-x
PRbs would mantain an elongating Pol II state by
regulating the enzyme activity per se and/or by displacing
negative elongation factors bound to DNA. Accordingly,
activated PR not only induces bcl-x expression but also
causes an increase in distal over proximal transcription.
Taking into account that elongation rate and pro-
cessivity are functionally distinct and at least partially sep-
arable phenomena in vivo, and that most so-called
elongation factors do not affect the rate at which Pol II
travels down the gene (73), the combined recruitment of
PR with CBP, GCN5 and P-TEFb to the different
intragenic PRbs could explain, at least partially, that the
increase in the Pol II abundance to the 30 gene region and
in the generation of full-length bcl-x transcripts would be
consequence of combinatorial and complementary effects
Figure 8. Schematic model of PR-dependent bcl-x transcription regulation. In the absence of hormone, the bcl-x gene presents a basal transcriptional
activity characterized by the presence of some RNA Pol II molecules transcribing the entire gene, whereas they are commonly from the DNA
template before reaching the 30-end. On R5020 addition, PR is recruited to the intragenic PRbs along with the HATs CBP y GCN5 and the positive
transcription elongation factor P-TEFb, favoring Pol II elongation. A higher number of Pol II molecules now are able to complete full-length
transcription.
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on the Pol II elongation steps. Thus, modulation of the
productive elongation could be a mechanism by which PR
induces transcription of target genes containing intragenic
PRbs. In a ﬁrst attempt to extend our ﬁndings, we
searched for genes that had similar characteristics to bcl-
x gene, comparable length and encompassing intragenic
instead of classical promoter/enhancer PRbs. Out of
three genes found, one of them, the ern1 gene showed
hormone-dependent regulation similar to bcl-x; thus,
taking into account the limitation in the number of
genes analyzed, further studies are required to clarify the
generality of this mechanism. However, results from the
ChIP-seq of PR combined with the data from RNA-seq
assays allow us to propose that internal PRbs are
accumulated in up- and downregulated genes. Thus,
more genes would follow the same trend as bcl-x,
making the mechanism of gene activation mediated by
intragenic PRbs a more general mechanism than originally
expected. Second, these sites would also be relevant in
hormone-dependent downregulation. How the speciﬁcity
is acquired is a question that requires more investigation,
but the existence of different pools of PR in the cell or the
chromatin context of the PRbs in up- and downregulated
genes are two interesting hypothesis that would explain, in
part, our observations.
Finally, several questions arise from this work: what is
the real outcome of P-TEFb recruitment to these
intragenic sites? What is the relevance of these intragenic
PRbs on other transcriptional steps? Are these sites able to
directly recruit factors involved in pre-RNA processing?
Here, we have also demonstrated that progestins are able
to regulate the relative abundance between two bcl-x
isoforms that are products of two alternative 50-splice
sites. This effect could be consequence of the increase in
Pol II elongation efﬁciency triggered by the activated PR.
In this sense, it was demonstrated that the decrease of Pol
II elongation efﬁciency by ultraviolet irradiation correl-
ates with an increase in the bcl-xS/bcl-xL ratio favoring
apoptosis (51), suggesting that Pol II elongation activity
would be directly associated with the alternative splicing
of this gene. On the other hand, PR could also locally
stimulate the recruitment of splicing factors on triggering
chromatin remodelling as was found for the SRs co-acti-
vators CAPER, which act as splicing factors associated to
hormone receptors (74,75).
In summary, intragenic PRbs distributed along bcl-x
intron would act as ‘ﬁlling stations’ needed to reﬁll the
elongating polymerase with factors required for its
proper travel along the gene and affecting the processing
of bcl-x pre-RNAs (Figure 8).
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